GlaxoSmithKline Pharmaceuticals Limited — Others, 13-05-2025: Change in Management

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting on approving the financial results for the quarter and year ended March 31, 2025. The company reported standalone revenue of Rs. 966.08 Cr and profit after tax of Rs. 919.06 Cr for the year. Consolidated revenue reached Rs. 974.37 Cr for the quarter with profit after tax at Rs. 927.58 Cr for the year. A final dividend of Rs. 42 per share has been declared. Dr. Sunita Maheshwari was re-appointed as an Independent Director for a second term, and Parikh & Associates were appointed as Secretarial Auditor for five years, pending shareholder approval. Deloitte Haskins & Sells LLP issued clean audit opinions on both standalone and consolidated results.